SeekingAlpha · Aug 7, 2026
Reckitt Benckiser: Core Brands Remain Undervalued Despite Mead Johnson Litigation Risk
Reckitt Benckiser (RKT) rated Buy: 21% peer discount, strong FY2025 growth/margins, and litigation risk update. Reda here for a detailed analysis.

